Alexios Tzannis,
Business Development Manager Life Sciences,
IMT Microtechnologies
Dr. Alexios Paul Tzannis has been working for IMT for 12 years and is responsible for developing the Life Science and Diagnostics activities of IMT AG. He studied Electrical Engineer M.Sc. at the technical University of Denmark (DTU) in the field of technical Holography. He received his Ph.D. at the ETH Zurich for his work at Paul Scherrer Institute in the field of resonant holographic Interferometry. Dr. Alexios Paul Tzannis has founded, hands-on experience in Micro- and Nanotechnology, MEMS, Optics and Optoelectronics, Spectroscopy, and Microfluidics.
MEMS & Microfluidic Commercialization by IMT Microtechnologies
Tuesday, 2 October 2018 at 14:00
Add to Calendar ▼2018-10-02 14:00:002018-10-02 15:00:00Europe/LondonMEMS and Microfluidic Commercialization by IMT MicrotechnologiesSELECTBIOenquiries@selectbiosciences.com
Microfluidics, or lab-on-a-chip technology, is a powerful tool positioned in the intersection of biotechnology, automation, and functional integration. Microfluidic devices can shuttle picoliter, and smaller, volumes of fluids into functional regions, enabling powerful in vitro diagnostics (IVD) harnessing everything from digital biology, to next generation sequencing, organs-on-a-chip, high-throughput cell-based assays, or high-density multifunctional chips for drug discovery and bioanalysis, while shrinking sample and reagent volumes. The overall complexity can be addressed by transferring MEMS production schemes and equipment into the field of microfluidics. Thanks to advances in laser machining, photolithography, etching automation, wafer bonding, functionalization, room temperature UV-adhesive bonding and other process improvements, glass and glass-hybrid materials are often both the best-performing and most cost-effective consumable material for Life Science and Diagnostics devices. Here IMT offers leading edge technologies with automated and standardized processes. In this paper we discuss the challenges and solutions of implementing WLP processes for products.
Add to Calendar ▼2018-10-01 00:00:002018-10-03 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization "Track B"SELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2018-10-02 14:00:002018-10-02 15:00:00Europe/LondonMEMS and Microfluidic Commercialization by IMT MicrotechnologiesSELECTBIOenquiries@selectbiosciences.com
